MARC details
000 -LEADER |
fixed length control field |
01421cam a2200385 a 4500 |
001 - CONTROL NUMBER |
control field |
12783836 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
KENaKMTC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20171107115030.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
020404s2001 sz b i000 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2002422191 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
924154547X |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)ocm49518423 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
B9K |
Transcribing agency |
B9K |
Modifying agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
lccopycat |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RA 401.W6 |
Item number |
c2001 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
362.1/782 |
Edition number |
2nd ed. |
245 00 - TITLE STATEMENT |
Title |
How to develop and implement a national drug policy. |
250 ## - EDITION STATEMENT |
Edition statement |
2nd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Geneva : |
Name of publisher, distributor, etc |
World Health Organization, |
Date of publication, distribution, etc |
c2001. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
viii, 83 p. ; |
Dimensions |
26 cm. |
500 ## - GENERAL NOTE |
General note |
Updates and replaces Guidelines for developing national drug policies, 1988. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references (p. 79-83). |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical policy. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs, Essential |
General subdivision |
standards. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug and Narcotic Control. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Utilization |
General subdivision |
standards. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Legislation, Drug. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Industry |
General subdivision |
legislation & jurisprudence. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Health Policy. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health Organization. |
740 0# - ADDED ENTRY--UNCONTROLLED RELATED/ANALYTICAL TITLE |
Uncontrolled related/analytical title |
Guidelines for developing national drug policies. |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
copycat |
d |
3 |
e |
ncip |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |
Edition |
2nd ed. |
Intials |
JAO |